Document is current
Any future updates will be listed below
-
Authors
Johansen, Andreas Ohrt https://orcid.org/0000-0002-7391-9945
Mølgaard, Jesper https://orcid.org/0000-0003-2062-9570
Rasmussen, Søren Straarup https://orcid.org/0000-0002-6297-2871
Gu, Ying https://orcid.org/0000-0003-4220-8902
Grønbæk, Katja Kjær https://orcid.org/0000-0003-3045-6909
Sørensen, Helge B. D. https://orcid.org/0000-0001-5716-7600
Aasvang, Eske Kvanner https://orcid.org/0000-0002-7131-2461
Meyhoff, Christian Sylvest https://orcid.org/0000-0002-4885-4609
-
Funding
Funding for this research was provided by:
Radiometer Medical Aps
Innovationsfonden (8056-00055B)
Kræftens Bekæmpelse (R150-A9865-16-S48)
Copenhagen Center for Health Technology
Isansys Ltd
A.P. Møller Foundation
Bispebjerg and Frederiksberg Hospital
Rigshospitalet
Danmarks Tekniske Universitet
Royal Library, Copenhagen University Library
- License Information
-
More Information
Article History
Received: 19 February 2022
Accepted: 3 May 2023
First Online: 17 May 2023
Declarations
:
: CSM, EKA and HBDS have founded a start-up company, WARD247 ApS, with the aim of pursuing the regulatory and commercial activities of the WARD-project (wireless monitoring of vital signs). WARD247 ApS has finalized terms for license agreement for any WARD-project software and patents and have one patent filed: “Wireless Assessment of Respiratory and circulatory Distress (WARD)—Clinical Support System (CSS)—an automated clinical support system to improve patient safety and outcomes”.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
